Antiangiogenic breast cancer treatment may benefit only patients with well-perfused t

[News]

A Massachusetts General Hospital (MGH) research team, in collaboration with investigators at the Dana-Farber Cancer Institute, may have found a reason why the use of antiangiogenesis drugs - which...

More... (http://www.medicalnewstoday.com/releases/301916.php)